BioStem Technologies, Inc. (BSEM) Reports Q1 Loss, Tops Revenue Estimates

BioStem Technologies reported a quarterly loss of $0.52 per share, worse than the Zacks Consensus Estimate for a $0.28 loss and down from earnings of $0.17 per share a year ago. The miss versus expectations and year-over-year deterioration point to weaker near-term fundamentals. The update is likely to pressure the stock, though the article contains no revenue or guidance details.

Analysis

BioStem Technologies reported a quarterly loss of $0.52 per share, worse than the Zacks Consensus Estimate for a $0.28 loss and down from earnings of $0.17 per share a year ago. The miss versus expectations and year-over-year deterioration point to weaker near-term fundamentals. The update is likely to pressure the stock, though the article contains no revenue or guidance details.